"infusion flow" is a correct and usable phrase in written English.
It refers to the movement or rate at which a liquid, such as medication or nutrients, is being infused into a person's body through a medical device or IV. Example: "The doctor carefully monitored the infusion flow to ensure the correct dosage of medication was being delivered to the patient."
After a 90-min equilibration period, the concentration of the infusate was multiplied by the infusion flow rate and divided by the mean of duplicate plasma samples at this and subsequent time points.
Leucine enkephalin was used as lockmass compound, infused at a concentration of 50 pg/µl at an infusion flow rate of 50 µl/min.
To assess whether the infusion flow rate influenced the perivascular distribution, 10 kDa fluorescein-labelled dextran was infused at either 1 or 2.5 μl/min.
The infusion flow rates and drug solution concentrations were controlled throughout the experiments.
Furthermore, it is well adapted to using mathematical optimization methods of drug infusion flow, choosing tumor population minimization as the objective function and healthy tissue preservation as a constraint.
Using experimental testing and a well-established heat exchanger design approach, the ɛ-NTU method, this paper examines the cooling performance of commercially available catheters as function of four practical parameters: (1) infusion flow rate, (2) catheter location in the body, (3) catheter configuration and design, and (4) cooling approach.
After 15 minutes were spent by the doctor trying to find a vein, the lethal infusion flowed.
The catheter was tunneled 8 10 cm subcutaneously and connected to an infusion pump delivering a continuous infusion (flow-rate: 4 mL/h for 48 h) of 190 mL ropivacaine (2 mg/mL) at 8 mg/h plus 2 mL ketorolac (30 mg/mL) at 1.25 mg/h.
When blood flow was examined following an infused doubling in plasma volume, both renal portal and ventral abdominal blood flow increased significantly during the 10 minute post infusion period but flow in the vessels leading to the kidneys was greater.
Following the 10 min post infusion period blood flow in all veins decreased rapidly and flows did not differ significantly from the pre infusion level (p > 0.29).
Reproducibility failure was associated with the variability in the length of infusion period and hence the flow rate on the excretion of the so formed Ca-EDTA complexes [ 4].
